Arlington’s Surescripts acquires ActiveRadar to arm doctors with better prescribing data


The deal positions Surescripts to “make it simpler and faster to get patients started on the best medication for them,” its CEO said.

Previous Stonelake Capital Partners closes $746M fund — its largest ever
Next Head of CIRM, California's stem cell research funding agency,to leave mid-month